Lakefront Biotherapeutics reported EUR147.02M in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
argenx SE USD 2.01B 352.94M Jun/2026
AstraZeneca USD 18.87B 11M Sep/2026
Biogen USD 2.38B 15.8M Sep/2026
Genmab DKK 1.22B 192M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.52B 451M Sep/2026
GRIFOLS EUR 1.08B 110M Sep/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Incyte USD 1.24B 111.82M Sep/2026
Merck EUR 4.89B 66M Sep/2026
Neurocrine Biosciences USD 957.3M 70.3M Sep/2026
Novartis USD 9.96B 109M Sep/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 326M 166M Sep/2026
UCB EUR 1.97B 54M Dec/2025
Vertex Pharmaceuticals USD 2.31B 176.7M Sep/2026